Third Forum 2002

Programme / Case-Studies

• Programme Details
• Case Studies
  • Access to treatment following clinical trials: the case of a pneumococcal conjugate vaccine trial in the Gambia
    
  • What are researchers' and institutions' responsibilities to the study community?
  • Obligations to Third Parties in the Face of Possible Harm
    
  • Is Community Consent Authentic and Legitimate?
    
  • Evaluating the use of traditional medicines
    
  • The wider implications of preventing mother-to child transmission of HIV, and subsequent management of women and children, in rural Uganda
    
    
• List of contributors
  • Prof Zulfiqar Ahmed Bhutta ( Aga Khan University , Pakistan )
  • Prof Sir Kenneth Calman ( University of Durham , UK )
  • Dr Dafna Feinholz-Klip (Instituto Nacional de Perinatalogia , Mexico )
  • Dr James Lavery (Fogarty International Centre, USA )
  • Dr Churchill Lukwiya Onen ( Princess Marina Hospital , Gaborone , Botswana )
  • Dr Malegapuru Makgoba (MRC, South Africa )
  • Prof Keith McAdam (MRC Laboratories, The Gambia )
  • Prof Ruth Macklin ( Albert Einstein College of Medicine, USA )
  • Prof. Partha P. Majumber (Indian Statistical Institute, India )
  • Dr Godwin Ndossi ( Tanzania Food & Nutrition Centre , Tanzania )
  • Dr Churchill Lukiwiya Onen ( Princess Marina Hospital , Botswana )
  • Dr Maarten Schim van der Loeff (MRC Laboratories, The Gambia)
  • Dr Peter Singer ( University of Toronto , Canada )
  • Professor Godfrey Tangwa ( University of Yaoundé, Cameroon )
  • Mr Douglas Wassenaar (University of Natal, South Africa)
  • Mr Nick Winterton (MRC, UK)